INS and type 2 diabetes mellitus: In addition, it is possible to capture the etiological heterogeneity that characterizes type 2 diabetes by generating “pathway-specific” polygenic scores with variants that share increased type 2 diabetes risk through specific pathophysiological processes such as impaired insulin secretion or different forms of insulin resistance [13].